Science
Thursday, 7/16, 04:29 AM
A therapy that aims to reset the body's clock reaches its first human test
- A US biotech company has dosed the first patient in a trial of ER-100, a treatment that tries to reverse cellular ageing by partly reprogramming cells.
- The early study targets blinding eye disease, and scientists caution that promise in animals is no guarantee in people.